Tiedemann Advisors’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $95.1K | Hold |
31,715
| – | – | ﹤0.01% | 268 |
|
|
2023
Q2 | $78K | Buy |
31,715
+1,500
| +5% | +$3.69K | ﹤0.01% | 252 |
|
|
2023
Q1 | $68.3K | Buy |
30,215
+10,000
| +49% | +$22.6K | ﹤0.01% | 242 |
|
|
2022
Q4 | $70.6K | Buy |
20,215
+10,000
| +98% | +$34.9K | ﹤0.01% | 234 |
|
|
2022
Q3 | $377K | Hold |
10,215
| – | – | 0.02% | 169 |
|
|
2022
Q2 | $194K | Buy |
+10,215
| New | +$194K | 0.01% | 215 |
|
|
2021
Q3 | – | Sell |
-55,556
| Closed | -$1.78M | – | 346 |
|
|
2021
Q2 | $1.78M | Hold |
55,556
| – | – | 0.07% | 117 |
|
|
2021
Q1 | $1.96M | Hold |
55,556
| – | – | 0.09% | 105 |
|
|
2020
Q4 | $1.78M | Sell |
55,556
-214,283
| -79% | -$6.87M | 0.09% | 108 |
|
|
2020
Q3 | $10.2M | Sell |
269,839
-12,753
| -5% | -$480K | 0.49% | 35 |
|
|
2020
Q2 | $12.6M | Hold |
282,592
| – | – | 0.67% | 27 |
|
|
2020
Q1 | $9.64M | Hold |
282,592
| – | – | 0.62% | 31 |
|
|
2019
Q4 | $11M | Buy |
+282,592
| New | +$11M | 0.53% | 41 |
|